Fiona Marshall to lead Novartis research centre

Saturday 17 September 2022
Appointee name
Fiona Marshall


Fiona Marshall, an experienced biotech executive, has been appointed president of the Novartis Institutes for BioMedical Research, effective 1 November, replacing James Bradner who has held the position since 2016. Dr Marshall is currently global head of discovery, preclinical development and translational medicines at Merck & Co Inc. Prior to this she was a founder and chief scientific officer of Heptares Therapeutics, a UK biotech focused on structure-based drug design. Heptares was acquired by the Sosei Group of Japan in 2015. Dr Marshall holds a BSc in biochemistry from the University of Bath and a PhD in neuroscience from the University of Cambridge, both in the UK.

Novartis announced the appointment on 1 September 2022.

Copyright 2022 Evernow Publishing Ltd